197 related articles for article (PubMed ID: 21332943)
41. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
Yashiki S; Fujiyoshi T; Arima N; Osame M; Yoshinaga M; Nagata Y; Tara M; Nomura K; Utsunomiya A; Hanada S; Tajima K; Sonoda S
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1047-61. PubMed ID: 11485622
[TBL] [Abstract][Full Text] [Related]
42. PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.
Kozako T; Yoshimitsu M; Fujiwara H; Masamoto I; Horai S; White Y; Akimoto M; Suzuki S; Matsushita K; Uozumi K; Tei C; Arima N
Leukemia; 2009 Feb; 23(2):375-82. PubMed ID: 18830259
[TBL] [Abstract][Full Text] [Related]
43. Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection.
Abdelbary NH; Abdullah HM; Matsuzaki T; Hayashi D; Tanaka Y; Takashima H; Izumo S; Kubota R
J Infect Dis; 2011 Apr; 203(7):948-59. PubMed ID: 21402546
[TBL] [Abstract][Full Text] [Related]
44. Adult T cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1.
Bangham CR; Toulza F
Adv Cancer Res; 2011; 111():163-82. PubMed ID: 21704832
[TBL] [Abstract][Full Text] [Related]
45. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.
Shimizu Y; Takamori A; Utsunomiya A; Kurimura M; Yamano Y; Hishizawa M; Hasegawa A; Kondo F; Kurihara K; Harashima N; Watanabe T; Okamura J; Masuda T; Kannagi M
Cancer Sci; 2009 Mar; 100(3):481-9. PubMed ID: 19154412
[TBL] [Abstract][Full Text] [Related]
46. HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.
Ando S; Hasegawa A; Murakami Y; Zeng N; Takatsuka N; Maeda Y; Masuda T; Suehiro Y; Kannagi M
J Immunol; 2017 Feb; 198(3):1210-1219. PubMed ID: 28011931
[TBL] [Abstract][Full Text] [Related]
47. Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.
Masaki A; Ishida T; Suzuki S; Ito A; Narita T; Kinoshita S; Ri M; Kusumoto S; Komatsu H; Inagaki H; Ueda R; Iida S
Cancer Sci; 2018 Aug; 109(8):2383-2390. PubMed ID: 29845702
[TBL] [Abstract][Full Text] [Related]
48. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Hanabuchi S; Masuda M; Ohashi T; Fukui F; Hasegawa A; Masuda T; Takaue Y; Okamura J; Kannagi M
Cancer Res; 2004 Jan; 64(1):391-9. PubMed ID: 14729650
[TBL] [Abstract][Full Text] [Related]
49. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
Tanaka Y; Nakasone H; Yamazaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Sato M; Terasako K; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
J Clin Immunol; 2012 Dec; 32(6):1340-52. PubMed ID: 22763862
[TBL] [Abstract][Full Text] [Related]
50. Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.
Sugata K; Yasunaga J; Mitobe Y; Miura M; Miyazato P; Kohara M; Matsuoka M
Blood; 2015 Aug; 126(9):1095-105. PubMed ID: 26063164
[TBL] [Abstract][Full Text] [Related]
51. Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.
Masamoto I; Yoshimitsu M; Kuroki A; Horai S; Ezinne CC; Kozako T; Hachiman M; Kamada Y; Baba M; Arima N
Leuk Lymphoma; 2016; 57(3):685-91. PubMed ID: 26077361
[TBL] [Abstract][Full Text] [Related]
52. Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.
Manuel SL; Schell TD; Acheampong E; Rahman S; Khan ZK; Jain P
J Leukoc Biol; 2009 Nov; 86(5):1205-16. PubMed ID: 19656902
[TBL] [Abstract][Full Text] [Related]
53. In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine.
Sagar D; Masih S; Schell T; Jacobson S; Comber JD; Philip R; Wigdahl B; Jain P; Khan ZK
Vaccine; 2014 May; 32(26):3274-84. PubMed ID: 24739247
[TBL] [Abstract][Full Text] [Related]
54. Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.
Ohashi T; Hanabuchi S; Kato H; Tateno H; Takemura F; Tsukahara T; Koya Y; Hasegawa A; Masuda T; Kannagi M
J Virol; 2000 Oct; 74(20):9610-6. PubMed ID: 11000233
[TBL] [Abstract][Full Text] [Related]
55. Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response.
Pique C; Connan F; Levilain JP; Choppin J; Dokhélar MC
J Virol; 1996 Aug; 70(8):4919-26. PubMed ID: 8763995
[TBL] [Abstract][Full Text] [Related]
56. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
Narita T; Ishida T; Masaki A; Suzuki S; Ito A; Mori F; Yamada T; Ri M; Kusumoto S; Komatsu H; Miyazaki Y; Takatsuka Y; Utsunomiya A; Niimi A; Iida S; Ueda R
J Immunol; 2014 Feb; 192(3):940-7. PubMed ID: 24363428
[TBL] [Abstract][Full Text] [Related]
57. Human T cell leukemia virus type I (HTLV-I) and human diseases.
Uchiyama T
Annu Rev Immunol; 1997; 15():15-37. PubMed ID: 9143680
[TBL] [Abstract][Full Text] [Related]
58. In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.
Izaki M; Yasunaga JI; Nosaka K; Sugata K; Utsunomiya H; Suehiro Y; Shichijo T; Yamada A; Sugawara Y; Hibi T; Inomata Y; Akari H; Melamed A; Bangham C; Matsuoka M
PLoS Pathog; 2021 Feb; 17(2):e1009271. PubMed ID: 33524072
[TBL] [Abstract][Full Text] [Related]
59. Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study.
Suehiro Y; Hasegawa A; Iino T; Sasada A; Watanabe N; Matsuoka M; Takamori A; Tanosaki R; Utsunomiya A; Choi I; Fukuda T; Miura O; Takaishi S; Teshima T; Akashi K; Kannagi M; Uike N; Okamura J
Br J Haematol; 2015 May; 169(3):356-67. PubMed ID: 25612920
[TBL] [Abstract][Full Text] [Related]
60. [Anti-tumor immunity in adult T-cell leukemia].
Kannagi M
Uirusu; 2004 Jun; 54(1):67-74. PubMed ID: 15449906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
